Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2025-12-24 @ 10:46 PM
NCT ID:
NCT05382169
Eligibility Criteria:
Inclusion Criteria:
* with hypermobile Ehlers Danlos syndrome
* with digestive disorders
* 14 years of age or older (minimum age for the MOS-SF 36 questionnaire)
* able to answer the questionnaires
* whose participation in a day hospital at Saint Vincent de Paul dedicated to the assessment of "functional digestive pain" is planned
* who do not object to the use of their health data for research purposes
Additional criteria for minors :
\- No objection to the use of health data for research purposes by parents/guardians
Exclusion Criteria:
* under guardianship or curatorship
* having taken a long-term high-dose antihistamine treatment (H1 or H2) during the last two months, according to the following thresholds :
* Desloratadine (\>5 mg/jour)
* Bilastine (\>20 mg/jour)
* Cetirizine (\>20 mg/jour)
* Ebastine (\>10 mg/jour)
* Fexofenadine (\>150 mg/jour)
* Levocetirizine (\>5 mg/jour)
* Loratadine (\>10 mg/jour)
* Exocetiridine (5 mg/jour)
* Mizolastine (\>10 mg/jour)
* Rupatadine (\>10 mg/jour)
* Polaramine (\>10 mg/jour)
* Oxomemazine (\>2 mg/jour)
* Hydroxyzine (\>25 mg/jour)
* Doxylamine (\>15 mg/jour)
* Cimetidine (\>200 mg/jour)
* Patients deprived of liberty, pregnant or nursing women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
14 Years
Study:
NCT05382169
Study Brief:
Protocol Section:
NCT05382169